Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in IPO/Stock Watch

Visen Pharma Plans Hong Kong IPO to Support Endocrine Therapies
Insilico Medicine, an AI Drug Company, Files for Hong Kong IPO
PegBio Plans Hong Kong IPO to Support Long Acting GLP-1 for Diabetes/Obesity
ArriVent Completes $175 Million NASDAQ IPO to Bring Assets from China to the US
Xtalpi, a Quantum Physics-AI Drug Discovery Company, Files for Hong Kong IPO
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital